A widely available and low-cost HIV medication, lamivudine, may offer new hope for millions of people suffering from diabetic macular edema (DME), a leading cause of vision loss among diabetics.

The study uncovered how HIV “hides,” an understanding that could help future treatments find and eradicate it.

In the state capitol Senators discussed a bill that could remove prior authorization from some life saving HIV medication.

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Haitians with HIV are defying stigma as they publicly denounce USAID cuts implemented by the administration of U.S. President Donald Trump that has led to a dwindling of life-saving medication ...

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

The timing is devastating: Scientists recently made a major advance in HIV prevention. Named the 2024 Breakthrough of the Year by the journal Science, the drug lenacapavir offers six months of HIV ...

Persons living with HIV (PLHIV) have been urged to strictly follow their antiretroviral medication as doing so will help ...